Bristol, United Kingdom
Carbometrics, headquartered in the United Kingdom, is a promising player in the Biotechnology industry, founded in 2018. Their mission, encapsulated in the slogan "Carbometrics aims to improve the lives of people with diabetes with new glucose sensor chemistry," underscores their commitment to medical innovation.
Operating from their base in Bristol at the Science Creates St Philips incubator, Carbometrics has leveraged its three state-of-the-art labs to pioneer advancements in glucose sensor technology. This journey builds on their previous experience under Ziylo, focusing on sensor development and drug discovery. Their in-house capabilities span a wide range of chemistry disciplines, alongside biochemistry, physics, and engineering expertise, poised for medical device innovation.
Recently, Carbometrics secured a €2.10M Venture Round investment on 05 May 2023, attracting investment from backers such as Parkwalk Advisors, Ada Ventures, SCVC, and Selvedge Venture, signaling strong confidence in their future potential.
